212 related articles for article (PubMed ID: 21538450)
1. Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.
Emerson SC; Rudser KD; Emerson SS
Stat Med; 2011 May; 30(11):1199-217. PubMed ID: 21538450
[TBL] [Abstract][Full Text] [Related]
2. Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials.
Flight L; Julious S; Brennan A; Todd S
Med Decis Making; 2022 May; 42(4):461-473. PubMed ID: 34859693
[TBL] [Abstract][Full Text] [Related]
3. On the efficiency of adaptive sample size design.
Cui L; Zhang L
Stat Med; 2019 Mar; 38(6):933-944. PubMed ID: 30450621
[TBL] [Abstract][Full Text] [Related]
4. Sample size adjustment designs with time-to-event outcomes: A caution.
Freidlin B; Korn EL
Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Optimal adaptive group sequential design with flexible timing of sample size determination.
Cui L; Zhang L; Yang B
Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
[TBL] [Abstract][Full Text] [Related]
7. Sample size adaptation designs and efficiency comparison with group sequential designs.
Cui L
Stat Med; 2024 May; 43(11):2203-2215. PubMed ID: 38545849
[TBL] [Abstract][Full Text] [Related]
8. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
Liu Q; Li G; Anderson KM; Lim P
J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
Levin GP; Emerson SC; Emerson SS
Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
[TBL] [Abstract][Full Text] [Related]
10. Efficient adaptive designs with mid-course sample size adjustment in clinical trials.
Bartroff J; Lai TL
Stat Med; 2008 May; 27(10):1593-611. PubMed ID: 18275090
[TBL] [Abstract][Full Text] [Related]
11. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
12. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.
Levin GP; Emerson SC; Emerson SS
Stat Med; 2013 Apr; 32(8):1259-75; discussion 1280-2. PubMed ID: 23081665
[TBL] [Abstract][Full Text] [Related]
13. An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials.
Mi MY; Betensky RA
Clin Trials; 2013 Apr; 10(2):207-15. PubMed ID: 23283576
[TBL] [Abstract][Full Text] [Related]
14. Adaptive trial designs.
Lai TL; Lavori PW; Shih MC
Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
[TBL] [Abstract][Full Text] [Related]
15. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
16. Issues in the use of adaptive clinical trial designs.
Emerson SS
Stat Med; 2006 Oct; 25(19):3270-96; discussion 3302-4, 3320-5, 3326-47. PubMed ID: 16906553
[TBL] [Abstract][Full Text] [Related]
17. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
Mauer M; Collette L; Bogaerts J;
Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
[TBL] [Abstract][Full Text] [Related]
18. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.
Boessen R; van der Baan F; Groenwold R; Egberts A; Klungel O; Grobbee D; Knol M; Roes K
Pharm Stat; 2013; 12(6):366-74. PubMed ID: 24214896
[TBL] [Abstract][Full Text] [Related]
19. Efficient group sequential designs when there are several effect sizes under consideration.
Jennison C; Turnbull BW
Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
[TBL] [Abstract][Full Text] [Related]
20. [Adaptive designs for clinical trial].
Li W; He SJ; Wang Y; Cheng XR; Jia X
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun; 28(6):605-7. PubMed ID: 17939395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
